Drug-labels.com

Pendo-Amiodarone: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
200 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Pendo-Amiodarone

ABOUT THIS MEDICATION

What the medication is used for:

  • Treatment of certain abnormal heart rhythms

    (arrhythmias).

What it does:

  • pendo-AMIODARONE has been prescribed to

    you by your doctor to restore or maintain a normal heart rhythm.

When it should not be used:

  • Do not use pendo-AMIODARONE if you are

    allergic to it or to any of the components of its formulation (see full list of components below). Contact your doctor immediately if you experience an allergic reaction or any severe or unusual side effects.

  • Do not use pendo-AMIODARONE if you have

    hepatitis, thyroid problems, or pulmonary disease (certain lung problems).

What the medicinal ingredient is:

pendo-AMIODARONE is available in tablets containing 200 mg as amiodarone hydrochloride.

What the nonmedicinal ingredients are:

The non-medicinal ingredients in pendo-AMIODARONE tablets are: colloidal silicon dioxide, FD&C Red dye No. 40 Lake, lactose monohydrate, magnesium stearate, povidone and sodium starch glycolate.

What dosage forms it comes in:

pendo-AMIODARONE 200 mg is available as an oral tablet.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

  • pendo-AMIODARONE is intended for use only in patients with the indicated life-threatening arrhythmias because its use is accompanied by substantial toxicity.
  • Pulmonary fibrosis (permanent scarring of the lungs) can occur and can be fatal.
  • Like other antiarrhythmics, pendo-

    AMIODARONE can worsen or start an irregular heartbeat (arrhythmias).

    • Liver injury is common with pendo-

      AMIODARONE, but is usually mild, however it can be serious and even fatal in some cases.

BEFORE you use pendo-AMIODARONE talk to your doctor if:

  • you have hepatitis, thyroid problems or lung abnormalities,
  • you are breast feeding, pregnant or planning on becoming pregnant,

  • anticipate undergoing any surgery,
  • you have any allergies to this drug or its ingredients or components of the container,
  • you are taking any medications (see

    INTERACTIONS WITH THIS MEDICATION).

Precautions when taking pendo-AMIODARONE Consult your doctor if you experience these or other side effects, as the dose may have to be adjusted:

  • pendo-AMIODARONE may cause a worsening of the existing arrhythmias or precipitate a new arrhythmia.
  • Both hyper- and hypothyroidism (too much or too little thyroid hormone released into the blood by the thyroid gland) may occur during, or soon after treatment with pendo-AMIODARONE.
  • One of the most serious complications is pulmonary (lung) toxicity, characterized by scarring or inflammation of the lungs. Clinical symptoms include cough, progressive shortness of breath, accompanied by weight loss and weakness.
  • pendo-AMIODARONE induces photosensitization in about 10% of patients. Sunscreen preparations or protective clothing may afford some protection to individual patients experiencing photosensitization. Blue-grey discoloration of exposed skin has been reported during long-term treatment. With discontinuation of therapy, the pigmentation fades slowly over a period of up to several years. The risk may be increased in patients of fair complexion or those with excessive sun exposure, and may be related to cumulative dose and duration of therapy.
  • Loss of vision or other visual disturbances

    such as visual halos or blurred vision.

  • Symptoms of nerve damage (peripheral

    neuropathy) such as pain, burning, or numbness.

INTERACTIONS WITH THIS MEDICATION

You should ensure that your doctor and pharmacist know all the medicines you are taking, prescription, non-prescription or herbal.

Drugs that may interact with pendo-AMIODARONE include:

Azoles, Cholestyramine, Beta blockers (e.g., propranolol), Calcium channel antagonists (e.g., verapamil), Cholesterol-lowering medications (e.g., simvastatin, atorvastatin), Cimetidine, Cyclosporine, Digitalis, Digoxin, Disopyramide, Fentanyl, Flecainide, Fluoroquinolones, Lidocaine, Macrolide Antibiotics, Phenytoin, Procainamide, Protease inhibitors (e.g., indinavir), Quinidine, Warfarin.

Grapefruit Juice and the herbal preparation St. John's Wort may also interact with pendo-AMIODARONE.

PROPER USE OF THIS MEDICATION

Usual Adult Dose:

  • It is very important that you take pendo-

    AMIODARONE exactly as your doctor has instructed.

  • Never increase or decrease the amount of

    pendo-AMIODARONE you are taking unless your doctor tells you to.

  • Loading Dose: normally 800 to

    1600 mg/day for 1 to 3 weeks (occasionally longer). Maintenance Dose: normally 600 to 800 mg/day for one month and then 200 to 400 mg/day (occasionally 600 mg/day).

  • pendo-AMIODARONE may be taken as a

    single daily dose, or in patients with severe gastrointestinal intolerance, as a twice a day dose.

Overdose:

What to do in case of overdose

In case of drug overdose, contact a health care
practitioner, hospital emergency department or
regional Poison Control Center immediately, even if
there are no symptoms.

Missed Dose:

If you happen to miss a dose, do not try to make up for it by doubling up on the dose next time. Just take your next regularly scheduled dose and try not to miss any more.

SIDE EFECTS AND WHAT TO DO ABOUT
THEM
  • You may experience side effects with the use of pendo-AMIODARONE.

    North American experience with chronic oral amiodarone hydrochloride therapy suggest that amiodarone associated adverse drug reactions are very common, having occurred in approximately 75% of patients taking 400 mg or more per day. The most serious adverse effects associated with the use of amiodarone hydrochloride involve your lungs, irregularities of your heart beat and hepatitis. Symptoms that suggest side effects relating to lung inflammation or scarring include: progressive shortness of breath, cough, weakness and weight loss. Symptoms that may suggest an irregularity of heart beat include: fainting, dizziness, light-headedness, weakness and chest pain.

    Your doctor should monitor your blood for liver function. The following symptoms may be signs of liver problems: prolonged nausea and vomiting, abdominal pain or discolouration of the skin.

    Other symptoms causing discontinuations less often have included disturbances of vision, reactions of the skin to sunlight, blue skin discoloration, eczema, hyperthyroidism and hypothyroidism.

    Hypotension (low blood pressure), while seen, is uncommon (less than 1%) during amiodarone hydrochloride tablets therapy. Chronic (i.e., long-term) administration of amiodarone hydrochloride tablets in rare instances may lead to the development of nerve damage (peripheral neuropathy) that may resolve when amiodarone hydrochloride is discontinued, but this resolution has been slow and incomplete (see Precautions when taking pendo-AMIODARONE).

Should you experience any of these while taking pendo-AMIODARONE, consult your doctor immediately.

SERIOUS SIDE EFFECTS, HOW OFTEN
THEY HAPPEN AND WHAT TO DO ABOUT
THEM
Symptom / effect

Talk with your

doctor or pharmacist In all cases

Stop taking drug and seek

immediate emergency medical

assistance

Tremor/abnormal involuntary movements, lack of

coordination, abnormal gait, dizziness

/
Blue skin discolouration/
Low blood pressure (fainting episodes, severe dizziness)/
Shortness of breath, chest pain, irregular heart beat, racing heart/
Bleeding abnormalities (excessive bruising, easy bleeding (e.g., when brushing teeth)/
Visual disturbances (halos or blurred vision), visual impairment/
Vomiting, abdominal pain, diarrhea/
Solar dermatitis/ photosensitivity (skin becomes sensitive to light)/
Paresthesias (sensation of tingling, burning, crawling of the skin) and Peripheral motor and sensory neuropathies (e.g., muscular weakness)/
Cognitive disturbances (e.g., confusion, inability to concentrate)/
Liver problems (e.g., yellowing skin or eyes, abdominal pain or vomiting)/
Alopecia (loss of hair)/

This is not a complete list of side effects. For any unexpected effects while taking pendo-AMIODARONE, contact your doctor or pharmacist.

HOW TO STORE IT

  • Keep bottle tightly closed.
  • Store between 15°C and 25°C.
  • Protect from light and excessive heat
  • Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

$ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program

    Health Canada

    Postal Locator 0701E

    Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect .

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting Pendopharm, a division of Pharmascience Inc., at 1-888-550-6060.

Pendopharm, a division of Pharmascience Inc. Montreal, Quebec

H4P 2T4

www.pendopharm.com

Last revised: July 28, 2014

REMINDER: This medicine has been prescribed only for you. Do not give it to anybody else. If you have any further questions, please ask your doctor or pharmacist.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02427346

Revision date stated in the text: July 28, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Pendo-Amiodarone

Rx or OTC
Prescription (Rx)?
DIN 02427346
Schedule(s) PRESCRIPTION
Active ingredient(s) Amiodarone hydrochloride 200 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01B Antiarrhythmics, class I and III
        1. C01BD Antiarrhythmics, class III
          1. C01BD01 Amiodarone
Company PENDOPHARM DIVISION OF PHARMASCIENCE INC
Current status Approved
Current status date July 31, 2014

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.